New Gene Replacement Clinical Trial Launched for RP Test
Tuesday, September 3 2024 | 08 h 46 min | Vision Science
ViGeneron in Munich, Germany has launched a new Phase 1b clinical trial testing a novel gene replacement therapy in individuals affected by...
Read More
New Treatment Target for AMD Identified
Tuesday, July 9 2024 | 13 h 35 min | Vision Science
For people living with wet age-related macular degeneration (AMD), the first line of treatment is anti-VEGF injections Anti-VEGF injections have...
Read More Clinical Trial Results for New Treatments for AMD and DME
Tuesday, May 14 2024 | 11 h 17 min | Vision Science
Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients However, they require...
Read More
Lessons From a Superfield Lens
Wednesday, March 20 2024 | 07 h 03 min | Vision Science
By Dr Jenny Lee, OD Aperture Contest Winner Aperture is the publication of the Canadian Association of Optometry Students Reprinted with...
Read More
Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...
Read More
